Peripheral immune-inducer dendritic cells drive early-life allergic inflammation
Summary
This Nature paper reports that a specialised subset of skin dendritic cells — termed peripheral immune‑inducer cDC2s (pii‑cDC2s) — potently drives allergen‑induced inflammation in early life. Using mouse pup models and human data overlays, the authors show that pup skin is hypersensitive to common allergens and fungal stimuli, with a distinct transcriptional response enriched for atopic‑dermatitis signatures. Key features include early activation of pii‑cDC2s, enrichment of dermal γδ T17 cells and a mixed TH2/TH17 cytokine milieu. Crucially, an immature hypothalamic–pituitary–adrenal (HPA) axis in pups (low corticosterone signalling) permits pii‑cDC2 activation; experimentally restoring glucocorticoid signalling suppresses the response. The work identifies dendritic cells (not macrophages or mast cells) as necessary local triggers of early‑life allergic skin inflammation and points to age‑dependent immune programming as a determinant of disease risk.
Key Points
- Pup (early‑life) skin shows heightened sensitivity to house dust mite (HDM), Alternaria and microbial stimuli, producing a rapid inflammatory response with TH2 and TH17 features.
- A distinct dendritic‑cell population (pii‑cDC2s) becomes activated in pup skin after allergen exposure and expresses genes such as Il12b, Ccl22, Ccl17 and Apol7c.
- Dendritic cells are necessary and sufficient to trigger local HDM inflammation in pups; macrophages and mast cells are largely dispensable for this early‑life response.
- Dermal γδ T17 cells are enriched and contribute to the inflammatory phenotype observed after allergen exposure in pups.
- Immature HPA axis activity (low corticosterone/GR signalling) in early life allows pii‑cDC2 activation; exogenous corticosterone or GR manipulation dampens the response.
- Protease activity in HDM is required for the effect, and the immune programme in pup skin overlaps with human atopic dermatitis transcriptional signatures.
Content summary
The authors combined in vivo mouse models (neonatal/pup versus adult), scRNA‑seq, bulk RNA‑seq, flow cytometry, genetic knockouts and pharmacological manipulations. After intradermal allergen challenge at postnatal day 4, pup skin developed rapid barrier perturbation, elevated TEWL and epidermal thickening. Transcriptomics revealed allergen‑induced gene programmes in pups that overlapped with human atopic dermatitis. Single‑cell profiling and enrichment experiments pinpointed a cDC2 subset (pii‑cDC2) that activates quickly in pups but not adults and produces chemokines and cytokine signals that recruit/activate effector lymphocytes. Depletion or genetic manipulation of dendritic cells reduced inflammation, while mast‑cell or macrophage depletion had little effect. The immature HPA axis in pups (reduced circulating corticosterone and GR responses) was shown to permissively allow pii‑cDC2 activation; corticosterone administration before allergen challenge suppressed pii‑cDC2 gene expression and the downstream inflammatory phenotype. The study therefore links developmental endocrine state, a specific dendritic‑cell activation programme and early‑life allergic skin disease susceptibility.
Context and relevance
This work addresses a major unanswered question in allergy/immunology: why infants are more prone to developing atopic skin inflammation. By identifying a dendritic‑cell driven, age‑dependent pathway, the paper connects developmental immunology (ontogeny of antigen‑presenting cells), neuroendocrine maturity (HPA axis) and environmental exposures (allergens, microbial products). For researchers and clinicians interested in atopic dermatitis, asthma prevention and early‑life immune programming, the findings suggest new cellular targets (pii‑cDC2s, their chemokines) and timeframe‑specific interventions (modulating glucocorticoid signalling or blocking dendritic‑cell activation) to prevent or mitigate disease onset.
Why should I read this?
Short version: if you care about why babies get eczema and how early exposures set lifelong allergy risk, this paper is gold. It drills down to a specific dendritic‑cell subset that flips the switch on infant skin inflammation and links it to the immature stress‑hormone system — so it’s actually actionable biology, not just a list of genes.
Author style
Punchy — the paper is written to spotlight a mechanistic discovery with clear translational implications. If you’re working on paediatric allergy, dermatology or immune development, the detailed methods and multiple orthogonal models make the findings especially worth reading in full.